Boehringer Ingelheim has taken an option on a family of compounds with potential as therapies for schizophrenia from Sosei Heptares, which it says could have broad activity against the symptoms of ...

Diagnosed with adult-onset schizophrenia shortly after his 24th birthday, the author transitioned from a perceived state of spiritual awakening to grappling with one of the most stigmatized illnesses.

The literature highlights the many aspects of TTM, quickly dispelling the notion that it is simply a habit. Christenson [4] has posited that TTM may be "... a heterogeneous condition composed of ...